| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:30 | SailPoint Q4 2026 slides: 28% ARR growth overshadowed by guidance | ||
| 15:30 | Jabil's Q2 FY2026 slides show strong beat, but stock declines 8.6% | ||
| 15:30 | SEALSQ partners with WISeSat to develop quantum satellite network | ||
| 15:30 | Elavon names Wally Mlynarski as new CEO | ||
| 15:30 | HealthEquity stock price target lowered to $100 by RBC on yield outlook | ||
| 15:30 | TD Cowen reiterates AstraZeneca stock rating on pipeline strength | ||
| 15:30 | UBS reiterates Buy on Eli Lilly stock amid GLP-1 pricing concerns | ||
| 15:30 | UBS raises Andersen Group stock price target on strong earnings | ||
| 15:30 | RBC Capital reiterates Constellation Brands stock rating on volume outlook | ||
| 15:30 | UBS cuts Docusign stock price target on growth outlook concerns | ||
| 15:30 | UBS cuts Nuscale Power stock price target on revised earnings outlook | ||
| 15:30 | RBC cuts Docusign stock price target on valuation to $55 from $70 | ||
| 15:30 | Craig-Hallum reiterates comScore stock rating on strong quarter | ||
| 15:30 | UBS cuts Academy Sports stock price target on uneven performance | ||
| 14:54 | Onfolio deploys AI agents across portfolio, cuts costs | ||
| 14:54 | Macy's Q4 FY25 slides: earnings beat forecasts, cautious 2026 outlook | ||
| 14:54 | H World 2025 slides: asset-light pivot drives profit surge amid RevPAR headwinds | ||
| 14:54 | Alimentation Couche-Tard Q3 2026 slides: EPS jumps 20%, eyes 10% growth | ||
| 14:54 | Canaccord cuts Neuronetics stock price target on valuation shift | ||
| 14:54 | Piper Sandler reiterates Freshpet stock rating on competitive edge | ||
| 14:54 | Piper Sandler reiterates Overweight on Chewy stock, $48 target | ||
| 14:54 | Piper Sandler reiterates Apollo Global stock rating on AI risk view | ||
| 14:54 | Piper Sandler reiterates Kestra Medical stock rating on strong Q3 | ||
| 14:54 | Rosenblatt reiterates Lumentum stock rating citing AI growth | ||
| 14:54 | Roth/MKM reiterates Buy rating on Sequans stock, $20 target |